Bekir Öztürk

468 total citations
27 papers, 351 citations indexed

About

Bekir Öztürk is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bekir Öztürk has authored 27 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Hematology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bekir Öztürk's work include Hematopoietic Stem Cell Transplantation (7 papers), Neutropenia and Cancer Infections (4 papers) and Antioxidant Activity and Oxidative Stress (2 papers). Bekir Öztürk is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Neutropenia and Cancer Infections (4 papers) and Antioxidant Activity and Oxidative Stress (2 papers). Bekir Öztürk collaborates with scholars based in Türkiye, Serbia and Ireland. Bekir Öztürk's co-authors include Ahmet Özet, Şeref Kömürcü, Fikret Arpacı, Selmin Ataergın, Perihan Güner, Vedat Işıkhan, Türker Çetin, Öner Balbay, Mahmut İlker Yılmaz and Mustafa Öztürk and has published in prestigious journals such as Cancer, Journal of Pineal Research and Nutrition.

In The Last Decade

Bekir Öztürk

27 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bekir Öztürk Türkiye 12 122 66 53 50 41 27 351
L. Geeraerts United States 7 162 1.3× 79 1.2× 95 1.8× 9 0.2× 30 0.7× 7 426
Alperen Korkmaz United States 5 66 0.5× 23 0.3× 64 1.2× 18 0.4× 10 0.2× 19 319
Flavia Di Bari Italy 15 46 0.4× 30 0.5× 58 1.1× 7 0.1× 31 0.8× 30 571
Uzay Görmüş Türkiye 16 80 0.7× 28 0.4× 235 4.4× 10 0.2× 27 0.7× 53 591
Amy Morrison United Kingdom 7 85 0.7× 22 0.3× 140 2.6× 54 1.1× 23 0.6× 17 439
Guo-Hong Yang China 9 45 0.4× 28 0.4× 97 1.8× 14 0.3× 43 1.0× 19 323
Koh Yamashita Japan 13 62 0.5× 25 0.4× 105 2.0× 9 0.2× 16 0.4× 40 402
Eva Malířová Czechia 12 98 0.8× 52 0.8× 63 1.2× 7 0.1× 22 0.5× 29 393
Audrey Jung Germany 13 167 1.4× 48 0.7× 97 1.8× 8 0.2× 21 0.5× 30 367
Brian Durham United Kingdom 10 81 0.7× 15 0.2× 102 1.9× 37 0.7× 44 1.1× 11 359

Countries citing papers authored by Bekir Öztürk

Since Specialization
Citations

This map shows the geographic impact of Bekir Öztürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bekir Öztürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bekir Öztürk more than expected).

Fields of papers citing papers by Bekir Öztürk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bekir Öztürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bekir Öztürk. The network helps show where Bekir Öztürk may publish in the future.

Co-authorship network of co-authors of Bekir Öztürk

This figure shows the co-authorship network connecting the top 25 collaborators of Bekir Öztürk. A scholar is included among the top collaborators of Bekir Öztürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bekir Öztürk. Bekir Öztürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydoğan, Ümit, et al.. (2016). Coping attitudes of cancer patients and their caregivers and quality of life of caregivers. Indian Journal of Palliative Care. 22(2). 150–150. 15 indexed citations
2.
Kanat, Özkan, Ahmet Özet, Selmin Ataergın, et al.. (2010). Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma. Medical Principles and Practice. 19(5). 344–347. 11 indexed citations
3.
Öztürk, Mustafa, Mehmet Özler, Yasemin Gülcan Kurt, et al.. (2010). Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicin‐ and trastuzumab‐induced cardiotoxicity. Journal of Pineal Research. 50(1). 89–96. 26 indexed citations
4.
Öztürk, Mustafa, Şeref Kömürcü, Selim Kılıç, et al.. (2009). Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation. Supportive Care in Cancer. 17(10). 1295–1299. 8 indexed citations
5.
Arpacı, Fikret, Mükerrem Safalı, Ahmet Özet, et al.. (2009). The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high‐dose chemotherapy in patients with Stage III breast cancer. Journal of Clinical Apheresis. 24(5). 197–204. 1 indexed citations
6.
Türk, Hacı Mehmet, et al.. (2008). Paraneoplastic Motor Neuron Disease Resembling Amyotrophic Lateral Sclerosis in a Patient with Renal Cell Carcinoma. Medical Principles and Practice. 18(1). 73–75. 13 indexed citations
8.
Özet, Ahmet, Bülent Kurt, Şeref Kömürcü, et al.. (2007). Impact of c-erb2 status on survival after high dose chemotherapy in high-risk breast cancer patients.. PubMed. 28(9). 1374–9. 3 indexed citations
9.
Beyan, Cenǵiz, et al.. (2007). The Effect of Radiologic Imaging Studies on the Risk of Secondary Malignancy Development in Patients with Hodgkin Lymphoma. Clinical Lymphoma & Myeloma. 7(7). 467–469. 7 indexed citations
10.
Güner, Perihan, Vedat Işıkhan, Şeref Kömürcü, et al.. (2006). Quality of Life and Sociodemographic Characteristics of Patients With Cancer in Turkey. Oncology nursing forum. 33(6). 1171–1176. 22 indexed citations
11.
12.
Işıkhan, Vedat, Şeref Kömürcü, Ahmet Özet, et al.. (2005). The Status of Alternative Treatment in Cancer Patients in Turkey. Cancer Nursing. 28(5). 355–362. 46 indexed citations
13.
Ural, Ali Uğur, Ferit Avcu, Mahmut İlker Yılmaz, et al.. (2005). Development of Squamous Cell Carcinoma of the Tongue during Induction Chemotherapy for Acute Myeloid Leukemia. Tumori Journal. 91(1). 81–83. 1 indexed citations
14.
Arpacı, Fikret, Türker Çetin, Ahmet Özet, et al.. (2004). The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS. Journal of Clinical Apheresis. 19(4). 197–201. 4 indexed citations
15.
Özet, Ahmet, et al.. (2003). A 10-Year Delayed Breast Cancer Patient with Unusual Widespread Cutaneous Involvement and Visceral Metastases. The Breast Journal. 9(1). 54–55. 1 indexed citations
16.
Çetin, Türker, Fikret Arpacı, Ahmet Özet, et al.. (2003). Stem cell mobilization by G‐CSF in solid and hematological malignancies: Single daily dose is better than split dose in obese patients. Journal of Clinical Apheresis. 18(3). 120–124. 4 indexed citations
17.
Çetin, Türker, Fikret Arpacı, Mustafa Turan, et al.. (2002). Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation. Nutrition. 18(7-8). 599–603. 34 indexed citations
18.
Öztürk, Bekir, Mehmet Güven, Fikret Arpacı, et al.. (2000). Plasma and Erythrocyte Lipid Peroxidation Levels in Patients with Testis Tumor After Orchiectomy. Biological Trace Element Research. 73(2). 181–188. 1 indexed citations
19.
Arslan, Nuri, Muhittin A. Serdar, Bekir Öztürk, et al.. (2000). Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis. Annals of Nuclear Medicine. 14(5). 395–399. 18 indexed citations
20.
Güven, Mehmet, Bekir Öztürk, Ahmet Sayal, & Ahmet Özet. (2000). Lipid peroxidation and antioxidant system in the blood of patients with Hodgkin’s disease. Clinical Biochemistry. 33(3). 209–212. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026